ORBIMED ADVISORS LLC Q1 2018 Filing
Filed May 15, 2018
Portfolio Value
$8.1B
Holdings
133
Report Date
Q1 2018
Filing Type
13F-HR
All Holdings (133 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | XRAYDENTSPLY SIRONA INC | 225,000 | $11.3B | 140.36% | |
| 102 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 866,593 | $9.7B | 120.67% | |
| 103 | —DBV TECHNOLOGIES S A | 410,700 | $9.5B | 117.48% | |
| 104 | FLBFLUIDIGM CORP DEL | 1,583,700 | $9.2B | 114.68% | |
| 105 | LAB 2.75 02/01/34FLUIDIGM CORP DEL | 10,000,000 | $8.5B | 105.08% | |
| 106 | ALKSALKERMES PLC | 145,000 | $8.4B | 104.20% | |
| 107 | —GW PHARMACEUTICALS PLC | 74,000 | $8.3B | 103.38% | |
| 108 | ATNXEURATHENEX INC | 430,000 | $7.3B | 90.69% | |
| 109 | NVTA1EURINVITAE CORP | 1,518,197 | $7.1B | 88.28% | |
| 110 | —INOTEK PHARMACEUTICALS CORP | 7,000,000 | $6.8B | 83.97% | |
| 111 | —FOAMIX PHARMACEUTICALS LTD | 1,250,000 | $6.4B | 79.51% | Call |
| 112 | KIDSORTHOPEDIATRICS CORP | 425,200 | $6.4B | 79.40% | |
| 113 | NBIXNEUROCRINE BIOSCIENCES INC | 75,000 | $6.2B | 77.12% | |
| 114 | SNDXSYNDAX PHARMACEUTICALS INC | 437,000 | $6.2B | 77.11% | |
| 115 | CRSPCRISPR THERAPEUTICS AG | 104,401 | $4.8B | 59.17% | |
| 116 | —SIERRA ONCOLOGY INC | 2,203,704 | $4.6B | 56.56% | |
| 117 | PRQRPROQR THRAPEUTICS N V | 1,302,955 | $4.0B | 49.68% | |
| 118 | —TESARO INC | 67,281 | $3.8B | 47.66% | |
| 119 | TEVATEVA PHARMACEUTICAL INDS LTD | 200,000 | $3.4B | 42.38% | Put |
| 120 | EX9EXELIXIS INC | 150,000 | $3.3B | 41.20% | Call |
| 121 | AUPHAURINIA PHARMACEUTICALS INC | 626,275 | $3.3B | 40.30% | |
| 122 | XENEXENON PHARMACEUTICALS INC | 634,812 | $3.1B | 38.57% | |
| 123 | RDHLGBPREDHILL BIOPHARMA LTD | 564,900 | $2.9B | 36.07% | |
| 124 | —MARINUS PHARMACEUTICALS INC | 567,600 | $2.2B | 26.88% | |
| 125 | —BIOHAVEN PHARMACTL HLDG CO L | 50,000 | $1.3B | 15.97% | Put |
| 126 | —BIOLINERX LTD | 1,038,600 | $904.0M | 11.21% | |
| 127 | MCRB1EURSERES THERAPEUTICS INC | 95,214 | $699.0M | 8.67% | |
| 128 | —AFFIMED N V | 326,650 | $604.0M | 7.49% | |
| 129 | —BIOMARIN PHARMACEUTICAL INC | 500,000 | $553.0M | 6.86% | |
| 130 | —BIOMARIN PHARMACEUTICAL INC | 500,000 | $515.0M | 6.39% | |
| 131 | —NOVELION THERAPEUTICS INC | 100,000 | $350.0M | 4.34% | |
| 132 | —ALIMERA SCIENCES INC | 250,000 | $258.0M | 3.20% | |
| 133 | —MEDIGUS LTD | 60,000 | $76.0M | 0.94% |
PreviousPage 2 of 2